Bio-Rad plans to redeem its $425 million 7½%, 6 1/8% senior notes

By Melissa Kory

Cleveland, Dec 6 - Bio-Rad Laboratories, Inc. said it intends to redeem all $225 million of its outstanding 7½% senior notes due 2013 and all $200 million of its outstanding 6 1/8% senior notes due 2014, using proceeds from a proposed offering of $425 million of senior notes due 2020 and cash on hand.

The company is a Hercules, Calif.-based manufacturer and distributor of life science research products and clinical diagnostics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.